318 related articles for article (PubMed ID: 34091179)
1. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.
Hashiesh HM; Sharma C; Goyal SN; Sadek B; Jha NK; Kaabi JA; Ojha S
Biomed Pharmacother; 2021 Aug; 140():111639. PubMed ID: 34091179
[TBL] [Abstract][Full Text] [Related]
2. Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice.
Berger G; Arora N; Burkovskiy I; Xia Y; Chinnadurai A; Westhofen R; Hagn G; Cox A; Kelly M; Zhou J; Lehmann C
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766439
[TBL] [Abstract][Full Text] [Related]
3. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S
Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise.
Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S
Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491
[TBL] [Abstract][Full Text] [Related]
5. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
[TBL] [Abstract][Full Text] [Related]
7. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner.
Meeran MFN; Laham F; Azimullah S; Sharma C; Al Kaabi AJ; Tariq S; Adeghate E; Goyal SN; Ojha S
Free Radic Biol Med; 2021 May; 167():348-366. PubMed ID: 33588052
[TBL] [Abstract][Full Text] [Related]
8. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.
Hashiesh HM; Jha NK; Sharma C; Gupta PK; Jha SK; Patil CR; Goyal SN; Ojha SK
Eur J Pharmacol; 2021 Oct; 909():174398. PubMed ID: 34332924
[TBL] [Abstract][Full Text] [Related]
10. β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.
Fidyt K; Fiedorowicz A; Strządała L; Szumny A
Cancer Med; 2016 Oct; 5(10):3007-3017. PubMed ID: 27696789
[TBL] [Abstract][Full Text] [Related]
11. Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction.
Asth L; Cruz LC; Soyombo N; Rigo P; Moreira FA
Curr Neuropharmacol; 2023; 21(2):213-218. PubMed ID: 36173065
[TBL] [Abstract][Full Text] [Related]
12. Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.
Ricardi C; Barachini S; Consoli G; Marazziti D; Polini B; Chiellini G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542177
[TBL] [Abstract][Full Text] [Related]
13. Plant Natural Sources of the Endocannabinoid (
Maffei ME
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906779
[TBL] [Abstract][Full Text] [Related]
14. Beta-caryophyllene is a dietary cannabinoid.
Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.
Hashiesh HM; Sharma C; Goyal SN; Jha NK; Ojha S
Front Pharmacol; 2021; 12():702675. PubMed ID: 34393784
[TBL] [Abstract][Full Text] [Related]
16. β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Aly E; Khajah MA; Masocha W
Molecules; 2019 Dec; 25(1):. PubMed ID: 31892132
[TBL] [Abstract][Full Text] [Related]
17. Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study.
Askari VR; Shafiee-Nick R
Biochem Pharmacol; 2019 Jan; 159():154-171. PubMed ID: 30529211
[TBL] [Abstract][Full Text] [Related]
18. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038
[TBL] [Abstract][Full Text] [Related]
19. Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?
Meza A; Lehmann C
Med Hypotheses; 2018 Jan; 110():68-70. PubMed ID: 29317072
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development.
Mlost J; Kac P; Kędziora M; Starowicz K
Neuropharmacology; 2022 Feb; 204():108908. PubMed ID: 34856202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
